In the study, published Tuesday in the journal The Lancet, researchers analyzed more than 58,000 participants to compare 30 ...
15hon MSN
Elironrasib may overcome resistance to prior KRAS G12C inhibition in non-small cell lung cancer
Elironrasib led to meaningful and durable responses in patients with metastatic KRAS G12C-mutated non-small cell lung cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results